Bioatla End Period Cash Flow vs Change In Cash Analysis

BCAB Stock

USD 1.57 0.09 5.42%

Bioatla financial indicator trend analysis is way more than just evaluating Bioatla prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bioatla is a good investment. Please check the relationship between Bioatla End Period Cash Flow and its Change In Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.

End Period Cash Flow vs Change In Cash

End Period Cash Flow vs Change In Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bioatla End Period Cash Flow account and Change In Cash. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Bioatla's End Period Cash Flow and Change In Cash is 0.41. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Change In Cash in the same time period over historical financial statements of Bioatla, assuming nothing else is changed. The correlation between historical values of Bioatla's End Period Cash Flow and Change In Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Bioatla are associated (or correlated) with its Change In Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Cash has no effect on the direction of End Period Cash Flow i.e., Bioatla's End Period Cash Flow and Change In Cash go up and down completely randomly.

Correlation Coefficient

0.41

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

End Period Cash Flow

Change In Cash

Most indicators from Bioatla's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bioatla current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.The current year's Sales General And Administrative To Revenue is expected to grow to 145.21, whereas Selling General Administrative is forecasted to decline to about 22.7 M.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.3M	1.2M	1.2M	1.2M
Interest Income	350K	1.6M	5.7M	6.0M

Depreciation And Amortization Interest Income

Bioatla fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.91	0.71	0.74	1.0	-0.62	0.94	0.64	0.91	-1.0	-0.47	0.18	1.0	0.66	0.77	-0.16	-0.91	1.0	-0.94	0.72	-0.88	0.56	0.89	-0.43	1.0	0.78
Short Long Term Debt Total	-0.91		-0.79	-0.78	-0.91	0.72	-0.99	-0.36	-0.97	0.9	0.68	-0.26	-0.91	-0.38	-0.8	0.42	0.92	-0.91	0.98	-0.82	0.94	-0.8	-0.93	0.51	-0.93	-0.73
Other Current Liab	0.71	-0.79		0.76	0.68	-0.19	0.85	0.38	0.89	-0.7	-0.88	0.52	0.7	0.4	0.9	-0.53	-0.88	0.7	-0.86	0.96	-0.6	0.86	0.93	0.03	0.73	0.9
Total Current Liabilities	0.74	-0.78	0.76		0.71	-0.44	0.8	0.31	0.83	-0.73	-0.59	0.68	0.74	0.34	0.96	-0.17	-0.91	0.74	-0.82	0.9	-0.8	0.67	0.77	0.04	0.74	0.57
Total Stockholder Equity	1.0	-0.91	0.68	0.71		-0.65	0.93	0.62	0.9	-1.0	-0.44	0.13	1.0	0.64	0.73	-0.15	-0.89	1.0	-0.94	0.69	-0.89	0.54	0.88	-0.48	1.0	0.75
Other Liab	-0.62	0.72	-0.19	-0.44	-0.65		-0.62	0.02	-0.56	0.63	0.11	0.18	-0.63	0.01	-0.3	0.05	0.47	-0.63	0.59	-0.27	0.87	-0.33	-0.45	0.81	-0.64	-0.09
Net Tangible Assets	0.94	-0.99	0.85	0.8	0.93	-0.62		0.48	0.99	-0.93	-0.71	0.28	0.94	0.5	0.85	-0.39	-0.96	0.94	-1.0	0.86	-0.9	0.8	0.96	-0.42	0.95	0.82
Property Plant And Equipment Net	0.64	-0.36	0.38	0.31	0.62	0.02	0.48		0.47	-0.62	-0.18	0.01	0.64	1.0	0.43	0.17	-0.53	0.64	-0.5	0.33	-0.27	0.15	0.45	-0.05	0.59	0.67
Current Deferred Revenue	0.91	-0.97	0.89	0.83	0.9	-0.56	0.99	0.47		-0.89	-0.77	0.38	0.91	0.49	0.89	-0.44	-0.97	0.91	-0.99	0.9	-0.87	0.85	0.96	-0.35	0.92	0.83
Net Debt	-1.0	0.9	-0.7	-0.73	-1.0	0.63	-0.93	-0.62	-0.89		0.43	-0.16	-1.0	-0.63	-0.76	0.13	0.9	-1.0	0.93	-0.71	0.88	-0.53	-0.89	0.42	-1.0	-0.76
Retained Earnings	-0.47	0.68	-0.88	-0.59	-0.44	0.11	-0.71	-0.18	-0.77	0.43		-0.57	-0.46	-0.19	-0.74	0.81	0.71	-0.46	0.71	-0.84	0.44	-0.97	-0.76	0.03	-0.5	-0.76
Accounts Payable	0.18	-0.26	0.52	0.68	0.13	0.18	0.28	0.01	0.38	-0.16	-0.57		0.18	0.03	0.66	-0.39	-0.5	0.18	-0.33	0.67	-0.21	0.5	0.38	0.55	0.18	0.33
Cash	1.0	-0.91	0.7	0.74	1.0	-0.63	0.94	0.64	0.91	-1.0	-0.46	0.18		0.66	0.77	-0.15	-0.91	1.0	-0.94	0.72	-0.88	0.56	0.89	-0.43	1.0	0.77
Non Current Assets Total	0.66	-0.38	0.4	0.34	0.64	0.01	0.5	1.0	0.49	-0.63	-0.19	0.03	0.66		0.46	0.16	-0.55	0.66	-0.51	0.35	-0.28	0.17	0.47	-0.05	0.61	0.68
Non Currrent Assets Other	0.77	-0.8	0.9	0.96	0.73	-0.3	0.85	0.43	0.89	-0.76	-0.74	0.66	0.77	0.46		-0.29	-0.96	0.77	-0.87	0.98	-0.73	0.76	0.87	0.08	0.78	0.77
Other Assets	-0.16	0.42	-0.53	-0.17	-0.15	0.05	-0.39	0.17	-0.44	0.13	0.81	-0.39	-0.15	0.16	-0.29		0.31	-0.15	0.39	-0.47	0.18	-0.77	-0.47	0.18	-0.19	-0.45
Long Term Debt	-0.91	0.92	-0.88	-0.91	-0.89	0.47	-0.96	-0.53	-0.97	0.9	0.71	-0.5	-0.91	-0.55	-0.96	0.31		-0.91	0.97	-0.93	0.85	-0.77	-0.94	0.17	-0.92	-0.82
Cash And Short Term Investments	1.0	-0.91	0.7	0.74	1.0	-0.63	0.94	0.64	0.91	-1.0	-0.46	0.18	1.0	0.66	0.77	-0.15	-0.91		-0.94	0.72	-0.88	0.56	0.89	-0.43	1.0	0.77
Common Stock Total Equity	-0.94	0.98	-0.86	-0.82	-0.94	0.59	-1.0	-0.5	-0.99	0.93	0.71	-0.33	-0.94	-0.51	-0.87	0.39	0.97	-0.94		-0.88	0.89	-0.79	-0.97	0.38	-0.96	-0.83
Common Stock Shares Outstanding	0.72	-0.82	0.96	0.9	0.69	-0.27	0.86	0.33	0.9	-0.71	-0.84	0.67	0.72	0.35	0.98	-0.47	-0.93	0.72	-0.88		-0.69	0.85	0.9	0.06	0.74	0.81
Non Current Liabilities Total	-0.88	0.94	-0.6	-0.8	-0.89	0.87	-0.9	-0.27	-0.87	0.88	0.44	-0.21	-0.88	-0.28	-0.73	0.18	0.85	-0.88	0.89	-0.69		-0.61	-0.79	0.55	-0.89	-0.49
Other Current Assets	0.56	-0.8	0.86	0.67	0.54	-0.33	0.8	0.15	0.85	-0.53	-0.97	0.5	0.56	0.17	0.76	-0.77	-0.77	0.56	-0.79	0.85	-0.61		0.8	-0.22	0.59	0.7
Other Stockholder Equity	0.89	-0.93	0.93	0.77	0.88	-0.45	0.96	0.45	0.96	-0.89	-0.76	0.38	0.89	0.47	0.87	-0.47	-0.94	0.89	-0.97	0.9	-0.79	0.8		-0.25	0.92	0.9
Total Liab	-0.43	0.51	0.03	0.04	-0.48	0.81	-0.42	-0.05	-0.35	0.42	0.03	0.55	-0.43	-0.05	0.08	0.18	0.17	-0.43	0.38	0.06	0.55	-0.22	-0.25		-0.44	-0.05
Net Invested Capital	1.0	-0.93	0.73	0.74	1.0	-0.64	0.95	0.59	0.92	-1.0	-0.5	0.18	1.0	0.61	0.78	-0.19	-0.92	1.0	-0.96	0.74	-0.89	0.59	0.92	-0.44		0.78
Property Plant And Equipment Gross	0.78	-0.73	0.9	0.57	0.75	-0.09	0.82	0.67	0.83	-0.76	-0.76	0.33	0.77	0.68	0.77	-0.45	-0.82	0.77	-0.83	0.81	-0.49	0.7	0.9	-0.05	0.78

Click cells to compare fundamentals

Bioatla Account Relationship Matchups

Bioatla fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.3M	244.9M	254.4M	225.7M	119.7M	159.6M
Short Long Term Debt Total	18.1M	682K	5.4M	4.0M	2.5M	2.3M
Other Current Liab	10.5M	10.0M	15.9M	15.9M	21.3M	14.8M
Total Current Liabilities	26.7M	32.3M	19.8M	23.1M	28.3M	25.6M
Total Stockholder Equity	(56.0M)	210.0M	210.8M	180.3M	70.7M	107.7M
Net Tangible Assets	(145.3M)	210.0M	210.8M	180.3M	207.4M	217.8M
Property Plant And Equipment Net	4.7M	4.1M	7.0M	5.2M	3.1M	5.1M
Net Debt	14.4M	(237.9M)	(239.6M)	(211.5M)	(109.0M)	(114.5M)
Retained Earnings	(148.4M)	(90.9M)	(186.3M)	(292.8M)	(416.3M)	(395.4M)
Accounts Payable	5.1M	2.5M	1.2M	4.2M	3.8M	3.4M
Cash	3.7M	238.6M	245.0M	215.5M	111.5M	151.3M
Non Current Assets Total	4.8M	4.3M	7.1M	5.3M	3.3M	5.3M
Cash And Short Term Investments	3.7M	238.6M	245.0M	215.5M	111.5M	151.3M
Liabilities And Stockholders Equity	9.3M	244.9M	254.4M	225.7M	119.7M	159.6M
Non Current Liabilities Total	38.6M	2.7M	23.8M	22.3M	20.6M	19.2M
Other Current Assets	214K	2.1M	2.3M	4.9M	9.6M	10.0M
Other Stockholder Equity	2.3M	300.9M	397.1M	473.1M	486.9M	304.7M
Total Liab	65.3M	35.0M	43.6M	45.4M	49.0M	37.8M
Net Invested Capital	(127.2M)	210.7M	210.8M	180.3M	70.7M	81.1M
Property Plant And Equipment Gross	4.7M	4.1M	11.2M	10.5M	9.2M	8.0M
Total Current Assets	4.5M	240.7M	247.3M	220.4M	116.4M	154.4M
Net Working Capital	(22.2M)	208.4M	227.5M	197.3M	88.1M	128.8M
Property Plant Equipment	4.7M	4.1M	7.0M	2.7M	3.1M	4.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Bioatla offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioatla's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatla Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatla Stock:

How To Invest In Bioatla

Details

Is Bioatla Stock a good investment?

Details

What is Bioatla's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.70)

Revenue Per Share

0.228

Quarterly Revenue Growth

0.316

Return On Assets

(0.50)

Return On Equity

(1.39)

The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bioatla End Period Cash Flow vs Change In Cash Analysis

End Period Cash Flow vs Change In Cash

End Period Cash Flow vs Change In Cash Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Change In Cash

Bioatla fundamental ratios Correlations

Bioatla Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bioatla fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity

Net Invested Capital	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Common Stock Total Equity	- 1.0	Net Tangible Assets
Net Debt	- 1.0	Total Stockholder Equity
Net Debt	- 1.0	Total Assets